Our look at the CBOE IPO concludes with a mostly positive view on the company and the deal. The only real sticking point is that the proposed pricing doesn't leave much - if anything - on the table for investors in the short term.
But it's a quality name that will be paying a dividend and may be able to exceed some of the forecasts that drive the valuation model. Until the dust settles we'd be a very price sensitive buyer of CBOE.
A snapshot diagram of the analysis . . .